To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

Bill: 116-hr-107
Sponsor: full_name: Rep. Burgess, Michael C. [R-TX-26]
Introduced: 2019-01-03
Policy area: Health
Subjects: Health care costs and insurance

Medicaid

Prescription drugs
Latest action: action_date: 2019-01-25
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2019-01-03
action_desc: Introduced in House
text: <p>This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100%&nbsp;of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020. </p>

tv_txt: I 116th CONGRESS 1st Session H. R. 107 IN THE HOUSE OF REPRESENTATIVES January 3, 2019 Mr. Burgess introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

1. Sunset of limit on maximum rebate amount for single source drugs and innovator multiple source drugs Section 1927(c)(2)(D) of the Social Security Act ( 42 U.S.C. 1396r–8(c)(2)(D) ) is amended by inserting after December 31, 2009, the following: and before January 1, 2020, .